Entry Point Capital, LLC Ideaya Biosciences, Inc. Call Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IDYA
# of Institutions
211Shares Held
73.8MCall Options Held
21.5KPut Options Held
20.3K-
Black Rock Inc. New York, NY6.81MShares$201 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.86MShares$143 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.27MShares$126 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X04.08MShares$120 Million0.08% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.74MShares$110 Million0.02% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.42B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...